LIQID - Model OptiShunt V1 - Flagship Device

The OptiShuntV1 is a proof of concept device designed to evaluate the safety, feasibility, and efficacy of patented technology for the treatment of glaucoma. The device is manufactured using world-class silicone micro moulding techniques according to ISO13485 guidelines and includes a custom shunt insertion system. Clinical trials are currently underway in the GOSSIP study being conducted at Groote Schuur tertiary academic Hospital, the home of the world’s first heart transplant.